Neurotech Short Long Term Debt vs Short Term Debt Analysis

NTI Stock

0.07 0 1.45%

Neurotech International financial indicator trend analysis is infinitely more than just investigating Neurotech International recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Neurotech International is a good investment. Please check the relationship between Neurotech International Short Long Term Debt and its Short Term Debt accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurotech International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Short Long Term Debt vs Short Term Debt

Short Long Term Debt vs Short Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Neurotech International Short Long Term Debt account and Short Term Debt. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Neurotech International's Short Long Term Debt and Short Term Debt is 0.15. Overlapping area represents the amount of variation of Short Long Term Debt that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of Neurotech International, assuming nothing else is changed. The correlation between historical values of Neurotech International's Short Long Term Debt and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt of Neurotech International are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Short Long Term Debt i.e., Neurotech International's Short Long Term Debt and Short Term Debt go up and down completely randomly.

Correlation Coefficient

0.15

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Short Long Term Debt

The total of a company's short-term and long-term borrowings.

Short Term Debt

Most indicators from Neurotech International's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Neurotech International current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurotech International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative is likely to drop to about 694.9 K in 2024. Issuance Of Capital Stock is likely to drop to about 6.4 M in 2024

	2021	2022	2023 (projected)
Cost Of Revenue	573.5K	1.7K	7.8K
Research Development	2.6M	6.5M	5.2M

Cost Of Revenue Research Development

Neurotech International fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Long Term Debt	Net Receivables	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Property Plant And Equipment Net	Net Debt	Non Current Assets Total	Non Currrent Assets Other	Other Assets
Total Assets		0.78	-0.28	0.89	-0.22	0.28	0.17	0.84	0.04	0.73	0.89	0.9	-0.1	-0.12	-0.41	0.99	-0.03	0.21	-0.04	0.78	0.66	0.67	-0.52	0.51	0.61	0.58
Other Current Liab	0.78		-0.41	0.57	-0.13	0.52	0.05	0.41	-0.33	0.28	0.92	0.86	0.24	-0.31	-0.6	0.72	-0.16	0.45	-0.34	0.72	0.64	0.79	-0.04	0.77	0.31	0.17
Total Current Liabilities	-0.28	-0.41		-0.41	-0.05	0.2	0.2	-0.36	0.07	0.01	-0.25	-0.23	-0.33	0.9	0.09	-0.3	0.16	-0.13	-0.31	-0.04	-0.03	-0.08	-0.26	-0.16	0.22	0.38
Total Stockholder Equity	0.89	0.57	-0.41		-0.03	-0.07	0.08	0.97	-0.04	0.71	0.63	0.61	-0.15	-0.3	-0.21	0.9	0.02	0.25	0.33	0.65	0.39	0.43	-0.59	0.36	0.31	0.48
Net Tangible Assets	-0.22	-0.13	-0.05	-0.03		-0.4	0.22	-0.1	-0.19	-0.22	-0.28	-0.36	0.0	0.04	0.41	-0.22	-0.49	0.36	0.36	-0.33	-0.29	-0.2	0.22	-0.03	-0.53	-0.13
Retained Earnings	0.28	0.52	0.2	-0.07	-0.4		-0.38	-0.15	-0.3	-0.14	0.62	0.53	-0.05	0.36	-0.47	0.19	0.36	0.26	-0.97	0.66	0.7	0.74	-0.09	0.69	0.33	0.02
Accounts Payable	0.17	0.05	0.2	0.08	0.22	-0.38		0.06	0.43	0.39	0.07	0.19	-0.03	0.08	-0.03	0.22	-0.61	-0.1	0.37	-0.27	-0.07	-0.14	0.19	-0.25	0.27	0.34
Cash	0.84	0.41	-0.36	0.97	-0.1	-0.15	0.06		0.11	0.77	0.53	0.55	-0.21	-0.22	-0.13	0.87	0.04	0.09	0.4	0.56	0.31	0.3	-0.69	0.18	0.4	0.56
Long Term Debt	0.04	-0.33	0.07	-0.04	-0.19	-0.3	0.43	0.11		0.44	-0.13	0.08	-0.04	0.11	0.51	0.13	-0.08	-0.7	0.27	-0.35	0.15	-0.19	0.07	-0.46	0.57	0.34
Net Receivables	0.73	0.28	0.01	0.71	-0.22	-0.14	0.39	0.77	0.44		0.44	0.57	-0.28	0.06	0.0	0.79	0.04	-0.38	0.32	0.34	0.31	0.17	-0.6	-0.08	0.71	0.74
Inventory	0.89	0.92	-0.25	0.63	-0.28	0.62	0.07	0.53	-0.13	0.44		0.97	0.06	-0.08	-0.57	0.84	0.0	0.34	-0.42	0.84	0.8	0.84	-0.27	0.72	0.54	0.37
Other Current Assets	0.9	0.86	-0.23	0.61	-0.36	0.53	0.19	0.55	0.08	0.57	0.97		0.04	-0.07	-0.53	0.88	-0.08	0.14	-0.34	0.72	0.76	0.75	-0.26	0.56	0.7	0.47
Other Stockholder Equity	-0.1	0.24	-0.33	-0.15	0.0	-0.05	-0.03	-0.21	-0.04	-0.28	0.06	0.04		-0.45	0.11	-0.11	-0.27	0.08	0.0	-0.12	0.0	0.02	0.43	0.08	-0.16	-0.05
Total Liab	-0.12	-0.31	0.9	-0.3	0.04	0.36	0.08	-0.22	0.11	0.06	-0.08	-0.07	-0.45		0.09	-0.14	0.12	-0.08	-0.43	0.09	0.14	0.07	-0.38	-0.06	0.35	0.47
Short Long Term Debt	-0.41	-0.6	0.09	-0.21	0.41	-0.47	-0.03	-0.13	0.51	0.0	-0.57	-0.53	0.11	0.09		-0.36	0.15	-0.41	0.38	-0.48	-0.15	-0.39	0.11	-0.41	-0.18	0.01
Total Current Assets	0.99	0.72	-0.3	0.9	-0.22	0.19	0.22	0.87	0.13	0.79	0.84	0.88	-0.11	-0.14	-0.36		-0.06	0.12	0.05	0.71	0.6	0.59	-0.52	0.41	0.64	0.61
Short Term Debt	-0.03	-0.16	0.16	0.02	-0.49	0.36	-0.61	0.04	-0.08	0.04	0.0	-0.08	-0.27	0.12	0.15	-0.06		-0.2	-0.33	0.38	0.28	0.15	-0.36	0.13	-0.01	-0.14
Intangible Assets	0.21	0.45	-0.13	0.25	0.36	0.26	-0.1	0.09	-0.7	-0.38	0.34	0.14	0.08	-0.08	-0.41	0.12	-0.2		-0.19	0.47	0.2	0.48	0.01	0.69	-0.4	-0.15
Common Stock	-0.04	-0.34	-0.31	0.33	0.36	-0.97	0.37	0.4	0.27	0.32	-0.42	-0.34	0.0	-0.43	0.38	0.05	-0.33	-0.19		-0.46	-0.57	-0.59	-0.07	-0.56	-0.24	0.09
Property Plant Equipment	0.78	0.72	-0.04	0.65	-0.33	0.66	-0.27	0.56	-0.35	0.34	0.84	0.72	-0.12	0.09	-0.48	0.71	0.38	0.47	-0.46		0.75	0.84	-0.56	0.78	0.36	0.36
Short Long Term Debt Total	0.66	0.64	-0.03	0.39	-0.29	0.7	-0.07	0.31	0.15	0.31	0.8	0.76	0.0	0.14	-0.15	0.6	0.28	0.2	-0.57	0.75		0.91	-0.15	0.76	0.58	0.3
Property Plant And Equipment Net	0.67	0.79	-0.08	0.43	-0.2	0.74	-0.14	0.3	-0.19	0.17	0.84	0.75	0.02	0.07	-0.39	0.59	0.15	0.48	-0.59	0.84	0.91		-0.13	0.94	0.43	0.21
Net Debt	-0.52	-0.04	-0.26	-0.59	0.22	-0.09	0.19	-0.69	0.07	-0.6	-0.27	-0.26	0.43	-0.38	0.11	-0.52	-0.36	0.01	-0.07	-0.56	-0.15	-0.13		0.0	-0.38	-0.69
Non Current Assets Total	0.51	0.77	-0.16	0.36	-0.03	0.69	-0.25	0.18	-0.46	-0.08	0.72	0.56	0.08	-0.06	-0.41	0.41	0.13	0.69	-0.56	0.78	0.76	0.94	0.0		0.09	-0.03
Non Currrent Assets Other	0.61	0.31	0.22	0.31	-0.53	0.33	0.27	0.4	0.57	0.71	0.54	0.7	-0.16	0.35	-0.18	0.64	-0.01	-0.4	-0.24	0.36	0.58	0.43	-0.38	0.09		0.72
Other Assets	0.58	0.17	0.38	0.48	-0.13	0.02	0.34	0.56	0.34	0.74	0.37	0.47	-0.05	0.47	0.01	0.61	-0.14	-0.15	0.09	0.36	0.3	0.21	-0.69	-0.03	0.72

Click cells to compare fundamentals

Neurotech International Account Relationship Matchups

Neurotech International fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	652.7K	80.8K	5.0M	2.0M	5.3M	12.2M
Other Current Liab	75.0K	8.4K	25.4K	72.9K	57.8K	35.9K
Total Current Liabilities	355.3K	727.1K	349.4K	593.0K	1.3M	314.7K
Total Stockholder Equity	297.4K	(646.3K)	3.9M	1.4M	4.0M	11.9M
Net Tangible Assets	297.4K	(646.3K)	3.9M	1.4M	4.0M	487.1K
Retained Earnings	(16.2M)	(17.9M)	(25.3M)	(28.7M)	(36.4M)	(41.6M)
Accounts Payable	154.2K	664.5K	324.0K	520.1K	1.3M	278.8K
Cash	474.7K	12.4K	4.8M	1.9M	3.0M	11.6M
Net Receivables	168.8K	59.3K	142.9K	99.5K	257.6K	318.1K
Inventory	71.0K	2.5K	2.4K	7.2K	7.8K	34.6K
Other Current Assets	9.3K	9.1K	35.7K	18.2K	16.8K	269.6K
Other Stockholder Equity	1.4M	1.0	(416.5K)	4.3M	65.5K	(144.3K)
Total Liab	355.3K	727.1K	1.1M	593.0K	1.3M	314.7K
Total Current Assets	652.7K	80.8K	5.0M	2.0M	5.3M	12.2M
Common Stock	15.1M	15.5M	25.8M	25.8M	34.4M	46.7M
Property Plant Equipment	374.2K	0.0	6.8K	2.6K	870.0	401.5K
Net Debt	41.8K	(4.8M)	(1.9M)	(3.0M)	(11.6M)	(11.0M)
Cash And Short Term Investments	12.4K	4.8M	1.9M	5.0M	11.6M	12.2M
Common Stock Shares Outstanding	154.6M	492.6M	697.3M	798.8M	912.0M	957.6M
Liabilities And Stockholders Equity	80.8K	5.0M	2.0M	5.3M	12.2M	12.8M
Accumulated Other Comprehensive Income	1.8M	3.4M	4.3M	6.0M	6.7M	7.1M
Net Invested Capital	(599.7K)	3.9M	1.4M	4.0M	11.9M	12.5M
Net Working Capital	(646.3K)	4.7M	1.4M	4.0M	11.9M	12.5M
Capital Stock	15.5M	25.8M	25.8M	34.4M	46.7M	29.9M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Neurotech Stock Analysis

When running Neurotech International's price analysis, check to measure Neurotech International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurotech International is operating at the current time. Most of Neurotech International's value examination focuses on studying past and present price action to predict the probability of Neurotech International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurotech International's price. Additionally, you may evaluate how the addition of Neurotech International to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC